Gold prices slip slightly after recent gains; U.S. data eyed
Investing.com - BMO Capital raised its price target on Ameren Corp . (NYSE:AEE) to $110.00 from $108.00 on Monday, while maintaining an Outperform rating on the utility company’s stock. The stock, currently trading near its 52-week high of $104.10, has delivered a strong 16.24% return year-to-date. According to InvestingPro analysis, the company appears to be trading above its Fair Value.
The price target increase follows Ameren’s second-quarter 2025 earnings report, which showed earnings per share of $1.01, in line with consensus estimates of $0.99.
Ameren management reaffirmed its 2025 guidance range of $4.85-5.05 per share, with a midpoint of $4.95, matching both BMO Capital and broader market consensus expectations.
The company also confirmed its five-year capital plan of $26.3 billion and maintained its long-term earnings per share growth target of 6-8%, with expectations to perform near the upper end of this range in the mid-to-latter part of the five-year plan.
BMO Capital noted that Ameren’s pipeline momentum is expected to drive approximately 9.2% compound annual growth rate in its rate base over the 2024-2029 period.
In other recent news, Ameren Corp reported financial results for the second quarter of 2025 that exceeded expectations. The company’s earnings per share (EPS) came in at $1.01, surpassing the forecast of $0.99. Additionally, Ameren reported a revenue of $2.22 billion, significantly higher than the anticipated $1.8 billion. These results highlight the company’s strong revenue growth during the quarter. In another development, Mizuho (NYSE:MFG) raised its price target for Ameren to $108 from $105, maintaining an Outperform rating. This adjustment follows Ameren’s reaffirmation of its 2025 earnings per share guidance, with expectations leaning toward the upper half of the $4.85-$5.05 range. Ameren also reiterated its 6%-8% EPS compound annual growth rate for 2025-2029, with projections toward the high end in the later years. These recent developments reflect positively on Ameren’s financial health and strategic outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.